Navigation Links
UBC, Max Planck formalize partnership among world's top quantum physicists
Date:10/4/2010

The University of British Columbia today forged a formal partnership with the Max Planck Society, Germany's foremost basic research institution and home to 32 Nobel prizes.

UBC President Stephen Toope and Max Planck Society President Peter Gruss were joined in Munich today by Thomas Marr, Germany's Minister-Counsellor of Commercial and Economic Affairs, for the signing of a memorandum of understanding (MOU) that will establish the Max Planck-UBC Centre for Quantum Materials.

The agreement also commits both institutions to conducting joint research projects in Canada and Germany, and to increasing scholarly exchanges.

"Today's agreement represents a joining of great strengths within both the Max Plank Society and UBC and will provide the underpinning for future research in advanced materials science," said Prof. Toope. "The knowledge and discoveries generated from these collaborations will profoundly change the lives of present and future generations."

The Max Planck-UBC Centre for Quantum Materials is only the third Max Planck Center to be established. The others are the Indo Max Planck Center for Computer Science in India and the CSIC-MPG Research Unit in Spain, which focuses on early European culture and religion. The first and only Max Planck Institute in North America is in Florida with Florida Atlantic University and is currently under construction.

Today's MOU signing also marks the start of the Max Planck Society-UBC "Summer School" on Quantum Materials involving five lecturers and 10 graduate students and post-doctoral fellows from UBC and a similar number of participants from Germany.

Established in 1948, the Max Planck Society for the Advancement of Science is a non-governmental, non-profit society that funds 80 institutes and research facilities in Germany and establishes strategic research partnerships with institutions around the world. Scientists from the society and its precursor, the Kaiser-Wilhelm-Society have earned 32 Nobel prizes since 1914.

UBC is world renowned for research excellence in quantum materials including superconductors with potential applications in lossless power lines, vast improvements in computers and wireless communications, new advances in solar and fuel cells and a new class of medical electronic devices to aid diagnosis and treatment. To date, four Canada Research Chairs (CRC) in the area of condensed matter physics have been awarded to researchers at UBC, more than any other university in the country.

UBC principal investigators to lead research groups in the new Max Planck-UBC Centre include four CRC's and five Fellows of the Royal Society of Canada two of whom are also fellows of the Royal Society of London. In addition, three of the researchers are among the 100 most cited physicists in the world. They will be led by Prof. George Sawatzky, Canada Research Chair in Physics and Chemistry of Nano-structured Materials.

"The partnership with Max Planck is a testament to the caliber of research conducted here, and our researchers enjoy reputations as some of the most internationally collaborative in the world," said John Hepburn, UBC Vice President Research and International, who added that 46 per cent of UBC research is published jointly with colleagues outside Canada.

"Our interdisciplinary research strengths are further complemented by state-of-the-art facilities such as UBC's Advanced Materials and Process Engineering Laboratory, our vicinity to TRIUMF, Canada's National Laboratory for Particle and Nuclear Physics, and priority access to the Canadian Light Source Synchrotron."

Over the past 50 years, engineers have succeeded in developing smaller combinations of semiconductors, insulators and metals arranged to function as electronic devices while maintaining their fundamental electronic properties. Scientists at the forefront of advanced materials research are investigating the dramatic changes in properties that occur when such devices dive below current size limitations.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related biology technology :

1. Neuroscience Symposium to Launch Max Planck Florida Institute and FAU New Graduate Program
2. Genedata's Refiner MS Used by Max Planck Institute will Demo at Metabolomics Conference 2010
3. Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox
4. BASF and Monsanto Formalize Agreement to Develop Dicamba-Based Formulation Technologies
5. Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
6. Epitomics, Inc. Announces Worldwide Availability of LRRK2 Antibodies Developed in Partnership With The Michael J. Fox Foundation
7. Pennsylvania Partnerships Address Statewide Nursing Shortage
8. DSM Biomedical Announces Continued Partnership with Spinelab
9. NanoPass Technologies Ltd. and Elcam Medical Enter Into a Strategic Partnership
10. Roche Diabetes Care and ICW Announce Technology Partnership
11. Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):